Targeted inhibition of glutaminase as a potential new approach for the treatment of <i>NF1</i> associated soft tissue malignanciesTahir Sheikh, Gary K. Schwartz|Oncotarget|2017Cited by 30
ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.Kristine Peregrino Lacuna, Matthew Ingham, Liner Ge et al.|Journal of Clinical Oncology|2023Cited by 1